Business Description
Initially developing in Mexico to then further expanding into additional Central and South American territories using prior clinical data in submission to the regulatory authorities of those regions. Its strategy is to develop a pipeline of API drug candidates, consisting of combinations of metal ions, indications, and administration methods.
